Search

everythinglearnresearchcommunity

for

Search:↓

A woman's excessive hair growth and high testosterone were caused by a rare ovarian tumor, which was successfully treated with surgery.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Methotrexate may help stabilize frontal fibrosing alopecia.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Strontium ranelate is no longer available for treatment.

Over-the-counter products can help with menopause symptoms, but be aware of their ingredients.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.

Dermoscopy helps diagnose frontal fibrosing alopecia by identifying specific scalp features.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.